Cargando…
CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation
SIMPLE SUMMARY: Chimeric antigen receptor (CAR)-T cell therapy has exhibited good application prospects in the treatment of hematologic malignancies. However, there are still many unsolved problems, such as the limited antitumor effect of CAR-T on solid tumors and the potential risk of CAR-T therapy...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072891/ https://www.ncbi.nlm.nih.gov/pubmed/33921581 http://dx.doi.org/10.3390/cancers13081955 |